Literature DB >> 14695457

Elevated concentration of soluble vascular endothelial cadherin is associated with coronary atherosclerosis.

Takeshi Soeki1, Yoshiyuki Tamura, Hisanori Shinohara, Koichi Sakabe, Yukiko Onose, Nobuo Fukuda.   

Abstract

BACKGROUND: Vascular endothelial (VE)-cadherin, a Ca(2+)-dependent cell adhesion molecule, is expressed in atherosclerotic lesions by endothelial cells and is associated with neovascularization, although the relationship between circulating VE-cadherin and coronary artery disease has not been studied. METHODS AND
RESULTS: The plasma concentration of VE-cadherin was measured in peripheral blood (femoral artery) and the coronary sinus of 24 patients with acute myocardial infarction (AMI), 26 with stable angina pectoris (AP), 18 with old myocardial infarction (OMI), and 30 control subjects (Control) who had no coronary artery stenosis on angiography. For the patients with AMI, blood samples were obtained in the acute (day 1) and chronic (day 21) phases. The plasma concentration of VE-cadherin was measured by enzyme-linked immunosorbent assay. The correlation between the plasma VE-cadherin concentration and the Gensini score was also determined as an index of the severity of coronary atherosclerosis. The plasma concentrations of VE-cadherin (ng/ml) in both the peripheral and coronary sinus blood were higher in patients with AMI, AP, and OMI than in the control subjects, and were similar in the 3 groups with coronary artery disease (femoral artery: AMI 5.1+/-2.5, AP 4.7+/-2.4, OMI 4.5+/-3.3, Control 2.6+/-2.3; coronary sinus: AMI 5.6+/-2.6, AP 5.0+/-2.3, OMI 5.0+/-2.9, Control 2.4+/-2.1, respectively). Plasma VE-cadherin concentrations were higher in the coronary sinus than peripheral blood samples in patients with AMI (p<0.01), AP (p<0.01), and OMI (p<0.05). The plasma VE-cadherin concentration was the same in the acute and chronic phases in patients with AMI. In the 3 groups of patients with coronary disease, both the peripheral plasma VE-cadherin concentration and the coronary sinus concentration correlated with the Gensini score (r=0.32, p<0.01 and r=0.42, p<0.001, respectively). Multiple regression analysis revealed that the plasma VE-cadherin concentration predicted the Gensini score independently of sex, age, hypertension, diabetes mellitus, smoking, and the lipid profiles.
CONCLUSION: Increased secretion of VE-cadherin from the epicardial arteries is associated with the degree of coronary atherosclerosis, indicating the presence of atherosclerosis rather than disease activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695457     DOI: 10.1253/circj.68.1

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  22 in total

Review 1.  Endothelial junction regulation: a prerequisite for leukocytes crossing the vessel wall.

Authors:  Anna E Daniel; Jaap D van Buul
Journal:  J Innate Immun       Date:  2013-04-03       Impact factor: 7.349

2.  Clinical significance of serum vascular endothelial-cadherin levels in inflammatory skin diseases.

Authors:  Haruka Kuriyama; Masatoshi Jinnin; Hisashi Kanemaru; Asako Ichihara; Akihiko Fujisawa; Chikako Moriya; Satoshi Fukushima; Hironobu Ihn
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

3.  Oxygen-Glucose Deprivation/Reoxygenation Induces Human Brain Microvascular Endothelial Cell Hyperpermeability Via VE-Cadherin Internalization: Roles of RhoA/ROCK2.

Authors:  Jie Chen; Li Sun; Gui-Bing Ding; Liang Chen; Lei Jiang; Jun Wang; Jin Wu
Journal:  J Mol Neurosci       Date:  2019-06-11       Impact factor: 3.444

4.  ADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signalling.

Authors:  Chongxiu Sun; Mack H Wu; Mingzhang Guo; Mark L Day; Eugene S Lee; Sarah Y Yuan
Journal:  Cardiovasc Res       Date:  2010-02-26       Impact factor: 10.787

5.  A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.

Authors:  Penelope M Drake; Birgit Schilling; Richard K Niles; Miles Braten; Eric Johansen; Haichuan Liu; Michael Lerch; Dylan J Sorensen; Bensheng Li; Simon Allen; Steven C Hall; H Ewa Witkowska; Fred E Regnier; Bradford W Gibson; Susan J Fisher
Journal:  Anal Biochem       Date:  2010-08-10       Impact factor: 3.365

6.  Activation of protein kinase C and disruption of endothelial monolayer integrity by sodium arsenite--Potential mechanism in the development of atherosclerosis.

Authors:  Flavia E Pereira; J Douglas Coffin; Howard D Beall
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-12       Impact factor: 4.219

7.  Increased serum levels of soluble vascular endothelial-cadherin in patients with systemic vasculitis.

Authors:  Tao Chen; Zai-Pei Guo; Na Cao; Sha Qin; Meng-Meng Li; Rui-Zhen Jia
Journal:  Rheumatol Int       Date:  2014-01-28       Impact factor: 2.631

Review 8.  Soluble cadherins as cancer biomarkers.

Authors:  Olivier De Wever; Lara Derycke; An Hendrix; Gert De Meerleer; François Godeau; Herman Depypere; Marc Bracke
Journal:  Clin Exp Metastasis       Date:  2007-10-19       Impact factor: 5.150

9.  ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.

Authors:  Beate Schulz; Jessica Pruessmeyer; Thorsten Maretzky; Andreas Ludwig; Carl P Blobel; Paul Saftig; Karina Reiss
Journal:  Circ Res       Date:  2008-04-17       Impact factor: 17.367

10.  Soluble vascular endothelial-cadherin in CSF after subarachnoid hemorrhage.

Authors:  Hajime Takase; Sherry Hsiang-Yi Chou; Gen Hamanaka; Ryo Ohtomo; Mohammad R Islam; Jong Woo Lee; Liangge Hsu; Justin Mathew; Estefania Reyes-Bricio; Kazuhide Hayakawa; Changhong Xing; Ming Ming Ning; Xiaoying Wang; Ken Arai; Eng H Lo; Josephine Lok
Journal:  Neurology       Date:  2020-02-27       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.